Outstanding Shares and Warrants -- 12.2 million shares, 852,000 warrants (including 167,000 at $2.85 expiring May 2026 and ...

Operator: Greetings. Welcome to the Bridgeline Digital Fourth Quarter 2025 Earnings Call. [Operator Instructions] Please note, this conference is being recorded.

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

President Trump’s job approval rating has rebounded after a second-term low, according to new polling averages from Decision Desk HQ (DDHQ). The president’s approval rating in the DDHQ average of ...

At the same time, several banks expect efficiency to increase by up to 30%. Even as companies race to roll out generative AI tools to be more competitive and productive, several hurdles are leading to ...

As early adopters have discovered, Copilot delivers real transformation only when it becomes an integral part of critical ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

President Trump’s approval rating has dropped slightly, according to a poll released Sunday. In the NBC News Decision Desk poll, 42 percent of respondents said they either “strongly approve” or ...

With nearly two decades of retail management and project management experience, Brett Day can simplify complex traditional and Agile project management philosophies and methodologies and can explain ...

Artificial intelligence (AI) is transforming the pharmaceutical industry, revolutionising drug discovery and approval processes, and reshaping how researchers identify potential drug candidates, ...

President Donald Trump's approval rating is showing signs of recovery, pollster Nate Silver has said. Writing in his Substack blog, Silver Bulletin, the statistician and political analyst said the ...